Cargando…

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma

N6-methyladenosine (m6A) is the most abundant mRNA modification in mammals and has been implicated in various biological processes. However, its role in hepatocellular carcinoma (HCC) remains largely unknown. In this study, we investigated the alterations of 19 main m6A regulatory genes in HCC and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pei, Wang, Xiaotong, Zheng, Lei, Zhuang, Chunbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567013/ https://www.ncbi.nlm.nih.gov/pubmed/33133142 http://dx.doi.org/10.3389/fgene.2020.540186

Ejemplares similares

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma
por: Yang, Xiawei, et al.
Publicado: (2022)

The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
por: Chen, Jianxing, et al.
Publicado: (2022)

N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020)

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma
por: Pan, Chenxi, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma
por: Song, ZeBing, et al.
Publicado: (2021)

Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
por: Jiang, Wenxiu, et al.
Publicado: (2023)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

The prognostic value and clinical significance of mitophagy-related genes in hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2022)

Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
por: Wang, Wei, et al.
Publicado: (2022)

Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma
por: Qin, Jiangfeng, et al.
Publicado: (2022)

Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
por: Wu, Xiaomin, et al.
Publicado: (2020)

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
por: Zhou, Zhiyang, et al.
Publicado: (2022)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
por: Ren, Huili, et al.
Publicado: (2022)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

Gene Signature and Identification of Clinical Trait-Related m(6) A Regulators in Pancreatic Cancer
por: Hou, Jie, et al.
Publicado: (2020)

Identification of a ferroptosis-related long noncoding RNA signature with a prognostic value in adrenocortical carcinoma
por: Wang, Weixi, et al.
Publicado: (2022)

Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
por: Bai, Yuping, et al.
Publicado: (2021)

Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
por: Ma, Keqiang, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma
por: Chen, Xingte, et al.
Publicado: (2021)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

The Construction of a Prognostic Model Based on a Peptidyl Prolyl Cis–Trans Isomerase Gene Signature in Hepatocellular Carcinoma
por: Shi, Huadi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ji76l3bhh9jjorqj9kpnd6s6rv